DONNINI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 12.262
EU - Europa 8.981
AS - Asia 4.937
SA - Sud America 739
Continente sconosciuto - Info sul continente non disponibili 280
AF - Africa 207
OC - Oceania 12
Totale 27.418
Nazione #
US - Stati Uniti d'America 12.091
GB - Regno Unito 2.098
RU - Federazione Russa 1.607
CN - Cina 1.582
SG - Singapore 1.493
IT - Italia 1.456
IE - Irlanda 1.131
SE - Svezia 628
BR - Brasile 623
VN - Vietnam 618
UA - Ucraina 586
FR - Francia 493
DE - Germania 433
HK - Hong Kong 397
FI - Finlandia 249
IN - India 237
KR - Corea 228
CA - Canada 87
BD - Bangladesh 84
ZA - Sudafrica 75
TR - Turchia 69
ES - Italia 60
NL - Olanda 58
MX - Messico 46
PL - Polonia 38
AR - Argentina 36
NG - Nigeria 36
BE - Belgio 35
IQ - Iraq 35
CI - Costa d'Avorio 31
ID - Indonesia 24
JP - Giappone 23
AT - Austria 21
EC - Ecuador 20
CO - Colombia 19
MA - Marocco 17
PK - Pakistan 16
NP - Nepal 14
VE - Venezuela 13
IL - Israele 12
PH - Filippine 12
UZ - Uzbekistan 12
KE - Kenya 11
DZ - Algeria 10
LT - Lituania 10
AU - Australia 9
CL - Cile 9
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
PT - Portogallo 8
RO - Romania 8
BO - Bolivia 7
JO - Giordania 7
CR - Costa Rica 6
GR - Grecia 6
GT - Guatemala 6
HN - Honduras 6
MY - Malesia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DK - Danimarca 5
EG - Egitto 5
ET - Etiopia 5
HU - Ungheria 5
IR - Iran 5
KG - Kirghizistan 5
OM - Oman 5
PE - Perù 5
RS - Serbia 5
EU - Europa 4
LU - Lussemburgo 4
TW - Taiwan 4
UY - Uruguay 4
AM - Armenia 3
BH - Bahrain 3
JM - Giamaica 3
KH - Cambogia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MM - Myanmar 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
PA - Panama 2
PY - Paraguay 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
Totale 27.125
Città #
Southend 1.867
Dallas 1.288
Dublin 1.115
Fairfield 1.073
Ashburn 1.020
Singapore 895
San Jose 710
Chandler 639
Houston 598
Woodbridge 498
Santa Clara 493
Jacksonville 487
Milan 425
Seattle 419
Wilmington 417
Moscow 412
Beijing 372
Hong Kong 372
Cambridge 353
Council Bluffs 298
Hefei 277
Ann Arbor 261
Seoul 227
Princeton 226
Siena 225
Los Angeles 177
The Dalles 160
Dong Ket 154
Menlo Park 147
Ho Chi Minh City 142
Rome 140
Nanjing 135
Hanoi 117
Helsinki 114
Lauterbourg 111
New York 111
Pune 101
Florence 92
Boardman 90
Munich 89
San Diego 81
Columbus 80
Fremont 66
San Mateo 66
Johannesburg 60
Buffalo 56
Bengaluru 52
São Paulo 49
Chicago 43
London 40
Tianjin 40
Orem 39
Redondo Beach 39
Nanchang 37
Turku 36
Brussels 35
Da Nang 35
Shanghai 35
Shenyang 35
Kunming 34
Abuja 33
Izmir 33
Dearborn 32
Abidjan 31
Brooklyn 31
Warsaw 31
Hebei 30
Málaga 30
Atlanta 29
Figino 28
Nuremberg 27
Phoenix 27
Chennai 26
Frankfurt am Main 26
San Francisco 25
Naples 24
Prato 24
Toronto 24
Montreal 23
Amsterdam 22
Lancaster 22
Tokyo 22
Turin 22
Denver 21
Haiphong 20
Jinan 20
Manchester 20
Changsha 19
Hangzhou 19
Mexico City 19
Zhengzhou 19
Norwalk 17
Belo Horizonte 16
Düsseldorf 16
Guangzhou 16
Padua 16
Boston 15
Bologna 14
Brasília 14
Jiaxing 14
Totale 18.722
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 448
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 431
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 406
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 358
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 343
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 327
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 317
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 311
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 309
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 305
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 303
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 299
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 285
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 281
Divergent effects of quercetin conjugates on angiogenesis 278
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 278
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 277
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 275
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 274
Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends 265
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 265
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 261
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 258
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 258
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 256
Development of phenol-enriched olive oil with phenolic compounds extracted from wastewater produced by physical refining 253
Biological characterization of nanocomposite hydrogels 251
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling 250
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 249
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 249
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 248
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 247
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 245
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 238
Activity of "NO-donor" or "NO-mediated" drugs 236
Studying vascular angiogenesis and senescence in zebrafish embryos 235
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 235
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 234
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction 234
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 225
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion 225
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 225
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 223
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 223
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 223
Role of nitric oxide in the modulation of angiogenesis 222
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis 222
Assessing vascular senescence in zebrafish 219
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 219
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 217
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 217
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 216
Differential contribution of bradykinin receptors in angiogenesis 215
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 214
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 212
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 212
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 210
Angiogenesis 209
Nitric oxide in tumor angiogenesis 207
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 206
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 206
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 205
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 204
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 203
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 201
Expression and localization of placenta growth factor and PlGF receptors in human meningiomas 199
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 199
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 196
Targeting Integrins in Cancer 194
Molecular mechanisms of resistance to anti-angiogenic drugs 194
Effect of Hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1 191
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 191
Nitric oxide and angiogenesis 189
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 187
Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? 186
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 186
Inflammation and tumor progression: role of prostaglandin E2 pathway 186
Oxidative Stress and Membrane Transport Systems 186
Repurposing of drugs for triple negative breast cancer: an overview 186
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 186
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 186
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 184
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 181
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 180
ETB receptors promote proliferation and migration of endothelial cells 179
Mitochondrial aldehyde dehydrogenase-2 activation prevents β amyloids induced endothelial cell dysfunction and restores angiogenesis. 179
Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1 178
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 178
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 178
Molecular mechanisms of VEGF-induced angiogenesis 177
Use of Nutraceuticals in Angiogenesis-Dependent Disorders 177
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 177
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 175
Low concentration of cetuximab treatment combined with DPE, a polyphenol of extra virgin olive oil, reduces colorectal cancer cell growth 172
Constitutive and inducible nitric oxide synthase: role in angiogenesis 171
Hydrogen peroxide mediates endothelium-dependent dilation of coronary arterioles in obese rats on low carbohydrate diet 171
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium 170
alpha(1D)-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed 170
Role of nitric oxide in tumor angiogenesis 166
Nitric oxide and PGE-2 cross-talk in EGFR-driven epithelial tumor cells 166
Totale 23.023
Categoria #
all - tutte 83.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.315 0 0 88 197 76 80 70 64 57 156 168 359
2022/20232.289 136 194 301 330 217 477 46 173 235 54 67 59
2023/20241.671 63 38 105 144 45 511 582 41 4 19 14 105
2024/20253.328 67 177 321 251 362 192 79 181 272 129 412 885
2025/20268.982 685 1.110 993 929 1.701 293 1.286 224 341 457 219 744
2026/20271.139 367 410 362 0 0 0 0 0 0 0 0 0
Totale 27.418